Machine learning and artificial intelligence bring many advantages to the development and efficacy of clinical diagnostics. Seegene, a molecular biotech company that specializes in diagnostics, has realized these capabilities and is leveraging an artificial intelligence-based big data system, as well as its own high multiplex PCR technologies, to shift the R&D paradigm for diagnostic tests away from manual R&D practices. The goal is to simplify and automate the R&D process so that companies can leverage their AI system to make diagnostics tests a reality and eliminate some of the challenges associated with traditional practices.
Read more on Labcompare.